| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model. | Yothaisong, S. Thanee, M. Namwat, N. Yongvanit, P. Boonmars, T. Puapairoj, A. Loilome, W. |
2014 | ||||
| 2. | Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Boonmars, T. Pairojkul, C. Yongvanit, P. |
2015 | ||||
| 3. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M Loilome, W Techasen, A Sugihara, E Okazaki, S Abe, S Ueda, S Masuko, T Namwat, N Khuntikeo, N Titapun, A Pairojkul, C Saya, H Yongvanit, P |
2016 | ||||
| 4. | Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 | ||||
| 5. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Jamnongkan, W. Thanee, M. Yongvanit, P. Loilome, W. Thanan, R. Namwat, N. Techasen, A. |
2018 | ||||
| 6. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 | ||||
| 7. | Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis | Anchalee Techasen Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Raynoo Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat |
2018 | ||||
| 8. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 | ||||
| 9. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Minerva Daya Watcharin Loilome Anchalee Techasen Malinee Thanee Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Nisana Namwat |
2018 | ||||
| 10. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 | ||||
| 11. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Loilome, W |
2020 | ||||
| 12. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Thongchot, S. Thanee, M. Loilome, W. Techasen, A. Titapun, A. Yongvanit, P. Namwat, N. |
2020 | ||||
| 13. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. | Thongchot, S Thanee, M Loilome, W Techasen, A Boonmars, T Sa-Ngiamwibool, P Titapun, A Yongvanit, P Isidoro, C Namwat, N |
2020 | ||||
| 14. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 | ||||
| 15. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. | Thanee, M. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Saya, H. Loilome, W. |
2020 | ||||
| 16. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 | ||||
| 17. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 | ||||
| 18. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Titapun, A. Thanee, M. Padthaisong, S. Duangkumpha, K. Suksawat, M. Loilome, W. Sithithaworn, P. Techasen, A. Thinkhamrop, B. Khuntikeo, N. |
2021 | ||||
| 19. | Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. | Prommajun, P Phetcharaburanin, J Namwat, N Klanrit, P Sa-Ngiamwibool, P Thanee, M Dokduang, H Kittirat, Y Li, JV Loilome, W |
2021 | ||||
| 20. | Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma | Phetcharaburanin, J. Namwat, N. Klanrit, P. Thanee, M. Dokduang, H. Loilome, W. |
2021 | ||||
| 21. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 | ||||
| 22. | Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients | Ainthachot, S Sa-Ngiamwibool, P Thanee, M Watcharadetwittaya, S Chamgramol, Y Pairojkul, C Deenonpoe, R |
2022 | ||||
| 23. | Diagnosis of Metastatic Carcinoma Using Body Cavity Fluid Specimens: A Comparison of Diagnostic Panels. | Sridakhun, N Intarawichian, P Thanee, M Watcharadetwittaya, S |
2022 | ||||
| 24. | Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma | Deenonpoe, R Sa-Ngiamwibool, P Watcharadetwittaya, S Thanee, M Intuyod, K Kongpan, T Padthaisong, S Nutalai, R Chamgramol, Y Pairojkul, C |
2022 | ||||
| 25. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 | ||||
| 26. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 | ||||
| 27. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 | ||||
| 28. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 | ||||
| 29. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 | ||||
| 30. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand | Koonmee, S Sangkhamanon, S Intarawichian, P Aphivatanasiri, C Kunprom, W Sa-Ngiamwibool, P Balthaisong, S Phuyao, C Prajumwongs, P Alaghehbandan, R Thanee, M |
2022 | ||||
| 31. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 | ||||
| 32. | Diagnosis of Metastatic Carcinoma Using Body Cavity Fluid Specimens: A Comparison of Diagnostic Panels | Sridakhun, N. Intarawichian, P. Thanee, M. Watcharadetwittaya, S. |
2023 | ||||
| 33. | Pathology of Cholangiocarcinoma. | Koonmee, S. Sa-ngiamwibool, P. Aphivatanasiri, C. Kunprom, W. Intarawichian, P. Bamrungkit, W. Sangkhamanon, S. Thanee, M. |
2023 | ||||
| 34. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines. | Janthamala, S. Promraksa, B. Thanee, M. Duenngai, K. Jusakul, A. Kongpetch, S. Kraiklang, R. Thanee, K. Pinlaor, P. Namwat, N. Saya, H. Techasen, A. |
2024 | ||||
| 35. | Antioxidant and Anticancer Potentials and Metabolic Profiling of Benjakul, A Thai Herbal Preparation | Duenngai, K. Promraksa, B. Janthamala, S. Thanee, M. Sirithawat, P. Wisungre, S. Deechan, S. Meechai, N. Paratang, P. Techasen, A. |
2024 | ||||
| 36. | Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning. | Panwoon, C Seubwai, W Thanee, M Sangkhamanon, S |
2024 | ||||
| 37. | Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells. | Armartmuntree, N Kittirat, Y Promraksa, B Loilome, W Dokduang, H Techasen, A Sansomchai, P Thanee, M O'Connor, T Kongthitilerd, P Padthaisong, S |
2025 | ||||
| 38. | Deep neural network-based prediction of RNA aptamers targeting E6 protein of high-risk human papilloma virus | Promraksa, B. Kittirat, Y. Boonyod, D. Phetumpai, C. Thanee, M. Techasen, A. |
2025 | ||||
| 39. | Discovery of a Copy-neutral Loss of Heterozygosity Pattern in Perihilar Cholangiocarcinoma With Potential Prognostic Value. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Techasen, A Klanrit, P Loilome, W Sa-Ngiamwibool, P Thanee, M |
2025 | ||||
| 40. | Distinct chromosome abnormality patterns for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma. | Ngamsangiam, W Techa-Ay, S Sa-Ngiamwibool, P Watcharadetwittaya, S Deenonpoe, R Techasen, A Sridakhun, N Padthaisong, S Thanee, M |
2025 | ||||
| 41. | Enhancing intracellular reactive oxygen species, apoptosis, and wound healing activities of Benjakul in cholangiocarcinoma | Janthamala, S. Pornpiphat, S. Techasen, A. Thanee, M. Wisungre, S. Deechan, S. Meechai, N. Paratang, P. Duenngai, K. |
2025 | ||||
| 42. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 | ||||
| 43. | Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma. | Amontailak, S Titapun, A Jusakul, A Thanan, R Kimawaha, P Jamnongkan, W Thanee, M Sirithawat, P Haohan, S Techasen, A |
2025 | ||||
| 44. | Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Sa-Ngiamwibool, P Panwoon, C Loilome, W Klanrit, P Techasen, A Chamgramol, Y Suksawat, M Armartmuntree, N O'Connor, T Saya, H Thanee, M |
2025 | ||||
| 45. | Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Kaewlert, W Techasen, A Loilome, W Klanrit, P Suksawat, M Chaleekan, K Sitthirak, S Thanee, M |
2025 | ||||
| 46. | Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer | Kaewkedsri, P Intarawichian, P Jessadapattarakul, S Kunprom, W Koonmee, S Thanee, M Somintara, O Wongbuddha, A Chadbunchachai, P Nawapun, S Aphivatanasiri, C |
2025 | ||||
| 47. | Vanillic Acid Suppresses Proliferation and Induces Apoptosis of Gastrointestinal Cancer Cells via Inhibition of mTOR Expression | Pornpiphat, S. Janthamala, S. Siriprayong, A. Duenngai, K. Wongwattanakul, M. Thanee, M. Pinlaor, P. Techasen, A. |
2025 | Count | 28 | 35 | 17 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Opisthorchis viverrini infection activates the PI3K/AKT/PTEN and Wnt/β-catenin signaling pathways in a cholangiocarcinogenesis model | Yothaisong, S. Thanee, M. Namwat, N. Yongvanit, P. Boonmars, T. Puapairoj, A. Loilome, W. |
2014 |
Asian Pacific Journal of Cancer Prevention 23 (15), pp. 10463-10468 |
||||||||
| 2. | Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Boonmars, T. Pairojkul, C. Yongvanit, P. |
2015 |
Asian Pacific Journal of Cancer Prevention 7 (16), pp. 3043-3050 |
||||||||
| 3. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science (), pp. |
||||||||
| 4. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science 7 (107), pp. 991-1000 |
||||||||
| 5. | Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process | Thanee, M. Techasen, A. Namwat, N. Yongvanit, P. Loilome, W. |
2017 |
Anticancer Research 7 (37), pp. 3591-3597 |
||||||||
| 6. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Jamnongkan, W. Thanee, M. Yongvanit, P. Loilome, W. Thanan, R. Namwat, N. Techasen, A. |
2018 |
PeerJ 1 (2018), pp. |
||||||||
| 7. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Loilome, W. Techasen, A. Thanee, M. Titapun, A. Yongvanit, P. Namwat, N. |
2018 |
OncoTargets and Therapy (11), pp. 395-408 |
||||||||
| 8. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 |
OncoTargets and Therapy (11), pp. 7019-7029 |
||||||||
| 9. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Thanee, M. Namwat, N. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Loilome, W. |
2020 |
BMC Cancer 1 (20), pp. |
||||||||
| 10. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Thongchot, S. Thanee, M. Loilome, W. Techasen, A. Titapun, A. Yongvanit, P. Namwat, N. |
2020 |
Journal of Traditional and Complementary Medicine 3 (10), pp. 230-235 |
||||||||
| 11. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 |
Drug Design, Development and Therapy (14), pp. 2319-2334 |
||||||||
| 12. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Thanee, M. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Saya, H. Loilome, W. |
2020 |
Journal of Translational Medicine 1 (18), pp. |
||||||||
| 13. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 |
PLoS ONE 3 March (16), pp. |
||||||||
| 14. | High levels of serum igg for opisthorchis viverrini and cd44 expression predict worse prognosis for cholangiocarcinoma patients after curative resection | Titapun, A. Thanee, M. Padthaisong, S. Duangkumpha, K. Suksawat, M. Loilome, W. Sithithaworn, P. Techasen, A. Thinkhamrop, B. Khuntikeo, N. |
2021 |
International Journal of General Medicine (14), pp. 2191-2204 |
||||||||
| 15. | Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma | Phetcharaburanin, J. Namwat, N. Klanrit, P. Thanee, M. Dokduang, H. Loilome, W. |
2021 |
Cancer Genomics and Proteomics 1 (18), pp. 29-42 |
||||||||
| 16. | Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients | Thanee, M. Chamgramol, Y. Pairojkul, C. Deenonpoe, R. |
2022 |
Human Pathology (126), pp. 31-44 |
||||||||
| 17. | Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma | Deenonpoe, R. Sa-Ngiamwibool, P. Watcharadetwittaya, S. Thanee, M. Intuyod, K. Kongpan, T. Padthaisong, S. Nutalai, R. Chamgramol, Y. Pairojkul, C. |
2022 |
Scientific Reports 1 (12), pp. |
||||||||
| 18. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P. Aphivatanasiri, C. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Wee, A. Koonmee, S. |
2022 |
HPB 11 (24), pp. 1944-1956 |
||||||||
| 19. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 |
Frontiers in Medicine (9), pp. |
||||||||
| 20. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 21. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand | Koonmee, S. Sangkhamanon, S. Intarawichian, P. Aphivatanasiri, C. Kunprom, W. Sa-Ngiamwibool, P. Balthaisong, S. Phuyao, C. Prajumwongs, P. Alaghehbandan, R. Thanee, M. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 22. | Diagnosis of Metastatic Carcinoma Using Body Cavity Fluid Specimens: A Comparison of Diagnostic Panels | Sridakhun, N. Intarawichian, P. Thanee, M. Watcharadetwittaya, S. |
2023 |
Acta Cytologica 3 (67), pp. 257-264 |
||||||||
| 23. | Pathology of Cholangiocarcinoma | Koonmee, S. Sa-ngiamwibool, P. Aphivatanasiri, C. Kunprom, W. Intarawichian, P. Bamrungkit, W. Sangkhamanon, S. Thanee, M. |
2023 |
Recent Results in Cancer Research (219), pp. 91-107 |
||||||||
| 24. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines | Janthamala, S. Promraksa, B. Thanee, M. Duenngai, K. Jusakul, A. Kongpetch, S. Kraiklang, R. Thanee, K. Pinlaor, P. Namwat, N. Saya, H. Techasen, A. |
2024 |
BMC Complementary Medicine and Therapies 1 (24), pp. |
||||||||
| 25. | Antioxidant and Anticancer Potentials and Metabolic Profiling of Benjakul, A Thai Herbal Preparation | Duenngai, K. Promraksa, B. Janthamala, S. Thanee, M. Sirithawat, P. Wisungre, S. Deechan, S. Meechai, N. Paratang, P. Techasen, A. |
2024 |
Tropical Journal of Natural Product Research 4 (8), pp. 6877-6883 |
||||||||
| 26. | Deep neural network-based prediction of RNA aptamers targeting E6 protein of high-risk human papilloma virus | Promraksa, B. Kittirat, Y. Boonyod, D. Phetumpai, C. Thanee, M. Techasen, A. |
2025 |
Journal of Associated Medical Sciences 3 (58), pp. 248-253 |
||||||||
| 27. | Enhancing intracellular reactive oxygen species, apoptosis, and wound healing activities of Benjakul in cholangiocarcinoma | Janthamala, S. Pornpiphat, S. Techasen, A. Thanee, M. Wisungre, S. Deechan, S. Meechai, N. Paratang, P. Duenngai, K. |
2025 |
Journal of Herbmed Pharmacology 3 (14), pp. 358-365 |
||||||||
| 28. | Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer | Kaewkedsri, P. Intarawichian, P. Jessadapattarakul, S. Kunprom, W. Koonmee, S. Thanee, M. Somintara, O. Wongbuddha, A. Chadbunchachai, P. Nawapun, S. Aphivatanasiri, C. |
2025 |
Breast Cancer Targets and Therapy (17), pp. 123-143 |
||||||||
| 29. | Vanillic Acid Suppresses Proliferation and Induces Apoptosis of Gastrointestinal Cancer Cells via Inhibition of mTOR Expression | Pornpiphat, S. Janthamala, S. Siriprayong, A. Duenngai, K. Wongwattanakul, M. Thanee, M. Pinlaor, P. Techasen, A. |
2025 |
Science Essence Journal 1 (41), pp. 39-50 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model. | Yothaisong, S Thanee, M Namwat, N Yongvanit, P Boonmars, T Puapairoj, A Loilome, W |
2014 |
Asian Pacific journal of cancer prevention : APJCP 23 (15), pp. 10463-8 |
|
| 2. | Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. | Thanee, M Loilome, W Techasen, A Namwat, N Boonmars, T Pairojkul, C Yongvanit, P |
2015 |
Asian Pacific journal of cancer prevention : APJCP 7 (16), pp. 3043-50 |
|
| 3. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. | Thanee, M Loilome, W Techasen, A Sugihara, E Okazaki, S Abe, S Ueda, S Masuko, T Namwat, N Khuntikeo, N Titapun, A Pairojkul, C Saya, H Yongvanit, P |
2016 |
Cancer science 7 (107), pp. 991-1000 |
|
| 4. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Padthaisong, S Thanee, M Techasen, A Namwat, N Yongvanit, P Liwatthakun, A Hankla, K Sangkhamanon, S Loilome, W |
2017 |
Anticancer research 7 (37), pp. 3591-3597 |
|
| 5. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. | Jamnongkan, W Thanee, M Yongvanit, P Loilome, W Thanan, R Kimawaha, P Boonmars, T Silakit, R Namwat, N Techasen, A |
2018 |
PeerJ (6), pp. e4281 |
|
| 6. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. | Daya, M Loilome, W Techasen, A Thanee, M Sa-Ngiamwibool, P Titapun, A Yongvanit, P Namwat, N |
2018 |
OncoTargets and therapy (11), pp. 395-408 |
|
| 7. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 |
OncoTargets and therapy (11), pp. 7019-7029 |
|
| 8. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. | Thongchot, S Thanee, M Loilome, W Techasen, A Boonmars, T Sa-Ngiamwibool, P Titapun, A Yongvanit, P Isidoro, C Namwat, N |
2020 |
Journal of traditional and complementary medicine 3 (10), pp. 230-235 |
|
| 9. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Dokduang, H Jamnongkarn, W Promraksa, B Suksawat, M Padthaisong, S Thanee, M Phetcharaburanin, J Namwat, N Sangkhamanon, S Titapun, A Khuntikeo, N Klanrit, P Loilome, W |
2020 |
Drug design, development and therapy (14), pp. 2319-2334 |
|
| 10. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Loilome, W |
2020 |
BMC cancer 1 (20), pp. 154 |
|
| 11. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 |
Journal of translational medicine 1 (18), pp. 64 |
|
| 12. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. | Thanee, M Dokduang, H Kittirat, Y Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Khuntikeo, N Wangwiwatsin, A Saya, H Loilome, W |
2021 |
PloS one 3 (16), pp. e0245871 |
|
| 13. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 |
International journal of general medicine (14), pp. 2191-2204 |
|
| 14. | Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. | Prommajun, P Phetcharaburanin, J Namwat, N Klanrit, P Sa-Ngiamwibool, P Thanee, M Dokduang, H Kittirat, Y Li, JV Loilome, W |
2021 |
Cancer genomics & proteomics 1 (18), pp. 29-42 |
|
| 15. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Thanee, M Padthaisong, S Suksawat, M Dokduang, H Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Wangwiwatsin, A Sa-Ngiamwibool, P Khuntikeo, N Saya, H Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 11 |
|
| 16. | Chromosomal aberrations, visualized using UroVysion® fluorescence in-situ hybridization assay, can predict poor prognosis in formalin-fixed paraffin-embedded tissues of cholangiocarcinoma patients. | Ainthachot, S Sa-Ngiamwibool, P Thanee, M Watcharadetwittaya, S Chamgramol, Y Pairojkul, C Deenonpoe, R |
2022 |
Human pathology (126), pp. 31-44 |
|
| 17. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand. | Koonmee, S Sangkhamanon, S Intarawichian, P Aphivatanasiri, C Kunprom, W Sa-Ngiamwibool, P Balthaisong, S Phuyao, C Prajumwongs, P Alaghehbandan, R Thanee, M |
2022 |
Frontiers in public health (10), pp. 792847 |
|
| 18. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 |
Frontiers in medicine (9), pp. 893252 |
|
| 19. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 11 (24), pp. 1944-1956 |
|
| 20. | Diagnosis of Metastatic Carcinoma Using Body Cavity Fluid Specimens: A Comparison of Diagnostic Panels. | Sridakhun, N Intarawichian, P Thanee, M Watcharadetwittaya, S |
2022 |
Acta cytologica (), pp. 1-8 |
|
| 21. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 |
Frontiers in oncology (12), pp. 1004220 |
|
| 22. | Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma. | Deenonpoe, R Sa-Ngiamwibool, P Watcharadetwittaya, S Thanee, M Intuyod, K Kongpan, T Padthaisong, S Nutalai, R Chamgramol, Y Pairojkul, C |
2022 |
Scientific reports 1 (12), pp. 8441 |
|
| 23. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 |
Frontiers in public health (10), pp. 816028 |
|
| 24. | Pathology of Cholangiocarcinoma. | Koonmee, S Sa-Ngiamwibool, P Aphivatanasiri, C Kunprom, W Intarawichian, P Bamrungkit, W Sangkhamanon, S Thanee, M |
2023 |
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (219), pp. 91-107 |
|
| 25. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 |
In vivo (Athens, Greece) 4 (37), pp. 1638-1648 |
|
| 26. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines. | Janthamala, S Promraksa, B Thanee, M Duenngai, K Jusakul, A Kongpetch, S Kraiklang, R Thanee, K Pinlaor, P Namwat, N Saya, H Techasen, A |
2024 |
BMC complementary medicine and therapies 1 (24), pp. 178 |
|
| 27. | Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning. | Panwoon, C Seubwai, W Thanee, M Sangkhamanon, S |
2024 |
PloS one 6 (19), pp. e0305252 |
|
| 28. | Programmed Cell Death Ligand 1 (PD-L1) and Major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in Triple-Negative Breast Cancer. | Kaewkedsri, P Intarawichian, P Jessadapattarakul, S Kunprom, W Koonmee, S Thanee, M Somintara, O Wongbuddha, A Chadbunchachai, P Nawapun, S Aphivatanasiri, C |
2025 |
Breast cancer (Dove Medical Press) (17), pp. 123-143 |
|
| 29. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 |
Scientific reports 1 (15), pp. 8621 |
|
| 30. | Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Sa-Ngiamwibool, P Panwoon, C Loilome, W Klanrit, P Techasen, A Chamgramol, Y Suksawat, M Armartmuntree, N O'Connor, T Saya, H Thanee, M |
2025 |
Scientific reports 1 (15), pp. 11984 |
|
| 31. | Distinct chromosome abnormality patterns for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma. | Ngamsangiam, W Techa-Ay, S Sa-Ngiamwibool, P Watcharadetwittaya, S Deenonpoe, R Techasen, A Sridakhun, N Padthaisong, S Thanee, M |
2025 |
PloS one 5 (20), pp. e0322408 |
|
| 32. | Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Kaewlert, W Techasen, A Loilome, W Klanrit, P Suksawat, M Chaleekan, K Sitthirak, S Thanee, M |
2025 |
Scientific reports 1 (15), pp. 20420 |
|
| 33. | Discovery of a Copy-neutral Loss of Heterozygosity Pattern in Perihilar Cholangiocarcinoma With Potential Prognostic Value. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Techasen, A Klanrit, P Loilome, W Sa-Ngiamwibool, P Thanee, M |
2025 |
Anticancer research 9 (45), pp. 3737-3748 |
|
| 34. | Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells. | Armartmuntree, N Kittirat, Y Promraksa, B Loilome, W Dokduang, H Techasen, A Sansomchai, P Thanee, M O'Connor, T Kongthitilerd, P Padthaisong, S |
2025 |
PloS one 1 (20), pp. e0317111 |
|
| 35. | Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma. | Amontailak, S Titapun, A Jusakul, A Thanan, R Kimawaha, P Jamnongkan, W Thanee, M Sirithawat, P Haohan, S Techasen, A |
2025 |
Cancer genomics & proteomics 1 (22), pp. 81-89 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/beta-catenin Signaling Pathways in a Cholangiocarcinogenesis Model | Supak Yothaisong Malinee Thanee Nisana Namwat Puangrat Yongvanit Thidarut Boonmars Anucha Puapairoj Watcharin Loilome |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 23.0 (15.0), pp. 10463.0-10468.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 2. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Eiji Sugihara Shogo Okazaki Shinya Abe Shiho Ueda Takashi Masuko Nisana Namwat Narong Khuntikeo Attapol Titapun Chawalit Pairojkul Hideyuki Saya Puangrat Yongvanit |
2016 |
CANCER SCIENCE 7.0 (107.0), pp. 991.0-1000.0 |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 3. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 |
ANTICANCER RESEARCH 7.0 (37.0), pp. 3591.0-3597.0 |
29 | 0 | 0 | 0 | 0 | 0 | 29 | |
| 4. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Rayno Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat Anchalee Techasen |
2018 |
PEERJ (6.0), pp. |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 5. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 |
CANCER SCIENCE (109.0), pp. 37.0-37.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis | Anchalee Techasen Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Raynoo Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat |
2018 |
CANCER SCIENCE (109.0), pp. 721.0-721.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 746.0-746.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 8. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Minerva Daya Watcharin Loilome Anchalee Techasen Malinee Thanee Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Nisana Namwat |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 395.0-408.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 9. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway | Sasikamon Khophai Malinee Thanee Anchalee Techasen Nisana Namwat Poramate Klanrit Attapol Titapun Apiwat Jarearnrat Prakasit Sa-Ngiamwibool Watcharin Loilome |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 7019.0-7029.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 10. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Watcharin Loilome |
2020 |
BMC CANCER 1.0 (20.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 11. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Suyanee Thongchot Malinee Thanee Watcharin Loilome Anchalee Techasen Thidarat Boonmars Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Ciro Isidoro Nisana Namwat |
2020 |
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE 3.0 (10.0), pp. 230.0-235.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 12. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 |
DRUG DESIGN DEVELOPMENT AND THERAPY (14.0), pp. 2319.0-2334.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 13. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Sakkarn Sungkhamanon Hideyuki Saya Watcharin Loilome |
2020 |
JOURNAL OF TRANSLATIONAL MEDICINE 1.0 (18.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Narong Khuntikeo Arporn Wangwiwatsin Hideyuki Saya Watcharin Loilome |
2021 |
PLOS ONE 3.0 (16.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 15. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Attapol Titapun Vor Luvira Tharatip Srisuk Apiwat Jareanrat Vasin Thanasukarn Malinee Thanee Prakasit Sa-Ngiamwibool Sureerat Padthaisong Kassaporn Duangkumpha Manida Suksawat Watcharin Loilome Paiboon Sithithaworn Anchalee Techasen Bandit Thinkhamrop Alexa Dzienny Ayse Caglayan David Park Simran Mahmud Narong Khuntikeo |
2021 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (14.0), pp. 2191.0-2204.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 16. | Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma | Pattama Prommajun Jutarop Phetcharaburanin Nisana Namwat Poramate Klanrit Prakasit Sa-Ngiamwibool Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jia Li Watcharin Loilome |
2021 |
CANCER GENOMICS & PROTEOMICS 1.0 (18.0), pp. 29.0-42.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|